JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M105365200 on August 8, 2001

J. Biol. Chem., Vol. 276, Issue 41, 37967-37973, October 12, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/41/37967    most recent
M105365200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by del C. Alonso, A.
Right arrow Articles by Iqbal, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by del C. Alonso, A.
Right arrow Articles by Iqbal, K.

Interaction of Tau Isoforms with Alzheimer's Disease Abnormally Hyperphosphorylated Tau and in Vitro Phosphorylation into the Disease-like Protein*

Alejandra del C. AlonsoDagger , Tanweer ZaidiDagger , Michal Novak§, Hector S. Barra, Inge Grundke-IqbalDagger , and Khalid IqbalDagger ||

From the Dagger  New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314,  Departmento de Química Biológica, Facultad de Ciencias Químicas, Centro de Investigaciones en Química Biológica de Córdoba-CONICET, Córdoba 5000, Argentina, and § Institute of Neuroimmunology, Slovak Academy of Sciences, Dubrovdka cesta 9, Bratislava 842 46, Slovak Republic

The microtubule-associated protein tau is a family of six isoforms that becomes abnormally hyperphosphorylated and accumulates in neurons undergoing neurodegeneration in the brains of patients with Alzheimer disease (AD). We investigated the isoform-specific interaction of normal tau with AD hyperphosphorylated tau (AD P-tau). We found that the binding of AD P-tau to normal human recombinant tau was tau 4L > tau 4S > tau 4 and tau 3L > tau 3S > tau 3, and that its binding to tau 4L was greater than to tau 3L. AD P-tau also inhibited the assembly of microtubules promoted by each tau isoform and caused disassembly when added to preassembled microtubules. This inhibition and depolymerization of microtubules by the AD P-tau corresponded directly to the degree of its interaction with the different tau isoforms. In vitro hyperphosphorylation of recombinant tau (P-tau) conferred AD P-tau-like characteristics. Like AD P-tau, P-tau interacted with and sequestered normal tau and inhibited microtubule assembly. These studies suggest that the AD P-tau interacts preferentially with the tau isoforms that have the amino-terminal inserts and four microtubule binding domain repeats and that hyperphosphorylation of tau appears to be sufficient to acquire AD P-tau characteristics. Thus, lack of amino-terminal inserts and extra microtubule binding domain repeat in fetal human brain might be protective from Alzheimer's neurofibrillary degeneration.


* These studies were supported in part by the New York State Office of Mental Retardation and Developmental Disabilities; National Institutes of Health Grants TW00507, AG05892, AG08076, and NS18105; and Consejo de Investigaciones Científicas y Tecnológicas de Córdoba and Secretaría de Ciencia y Tecnología-Universidad Nacional de Córdoba grants (Córdoba, Argentina).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Rd., Staten Island, NY 10314. Tel.: 718-494-5259; Fax: 718-494-1080; E-mail: kiqbal@admin.con2.com.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. P. Hanger, H. L. Byers, S. Wray, K.-Y. Leung, M. J. Saxton, A. Seereeram, C. H. Reynolds, M. A. Ward, and B. H. Anderton
Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis
J. Biol. Chem., August 10, 2007; 282(32): 23645 - 23654.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Liu, K. Iqbal, I. Grundke-Iqbal, S. Rossie, and C.-X. Gong
Dephosphorylation of Tau by Protein Phosphatase 5: IMPAIRMENT IN ALZHEIMER'S DISEASE
J. Biol. Chem., January 21, 2005; 280(3): 1790 - 1796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. d. C. Alonso, A. Mederlyova, M. Novak, I. Grundke-Iqbal, and K. Iqbal
Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations
J. Biol. Chem., August 13, 2004; 279(33): 34873 - 34881.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Suo, M. Wu, B. A. Citron, R. E. Palazzo, and B. W. Festoff
Rapid Tau Aggregation and Delayed Hippocampal Neuronal Death Induced by Persistent Thrombin Signaling
J. Biol. Chem., September 26, 2003; 278(39): 37681 - 37689.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.